Prescription drug abuse and black market sales are driving up demand for drug screening devices. Furthermore, there is a growing interest in creating drug screening tools that are more effective and efficient.
The Drug Screening Market is likely to thrive at a strong CAGR of 16.1% between 2023 and 2033. The market is anticipated to cross a market share of US$ 32.4 billion by 2033 while it is valued at US$ 7.3 billion in 2023.
There are more and more people using drugs of all kinds, and there are also more and more treatment centres, according to a study report on the drug screening sector. Sales of drug screening technologies are also increasing as a result of the new government restrictions that prohibit drug use and drug trafficking. The distribution of narcotics by drug users who support violence and drug abuse is under pressure from authorities to be restricted.
Prescription drug abuse and black market sales are driving up demand for drug screening devices. Furthermore, there is a growing interest in creating drug screening tools that are more effective and efficient. The rise in young people's usage of recreational drugs is driving up demand for advanced drug screening devices.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14265
Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14265
Key Points
Competitive Landscape:
The key players focus on providing drug screening solutions at cheaper prices while making these products portable, efficient, and effective. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: Laboratory Corporation of America Holdings, Hoffmann -La Roche Ltd, BioMerieux SA, Bio-Rad Laboratories Inc., Biomedical Diagnostics
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14265
For instance:
- Bio-Rad Laboratories Inc has introduced its Bio-Rad which works on different concepts such as target discovery, lead discovery, preclinical research, and Progress development. This has extended the research and development programs for the brand.
- BioMerieux SA has completed its 60 years in the service. This has resulted in the biomerieux and InDevR partnership of 5 million. This will be the exclusive distributor in Europe of VaxArray.
Key Segments:
By Sample Type:
By Product and Service:
Use promo code >> FMITODAY to get flat 20% discount
By End User:
By Region:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Jun 11, 2023